Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Christ

Showing results (91-100 of 100) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 100 results.
Cell Reports|January 29, 2022
Maintenance of broad neutralizing antibodies and memory B cells 1 year post-infection is predicted by SARS-CoV-2-specific CD4+ T cell responsesHarikrishnan Balachandran, Chansavath Phetsouphanh, David Agapiou, et al.
Plos Medicine|July 6, 2021
SARS-CoV-2 neutralizing antibodies: Longevity, breadth, and evasion by emerging viral variantsFiona Tea, Alberto Ospina Stella, Anupriya Aggarwal, et al.
Journal of Clinical Immunology|April 30, 2021
Genomic Spectrum and Phenotypic Heterogeneity of Human IL-21 Receptor DeficiencyDeniz Cagdas, Daniel Mayr, Safa Baris, et al.
Nature Communications|August 14, 2019
CAF hierarchy driven by pancreatic cancer cell p53-status creates a pro-metastatic and chemoresistant environment via perlecanClaire Vennin, Pauline Mélénec, Romain Rouet, et al.
Cell|February 16, 2020
Lymphoma Driver Mutations in the Pathogenic Evolution of an Iconic Human AutoantibodyMandeep Singh, Katherine J L Jackson, Jing J Wang, et al.
Clinical Immunology (Orlando, Fla.)|December 20, 2022
Tracking the clonal dynamics of SARS-CoV-2-specific T cells in children and adults with mild/asymptomatic COVID-19Weng Hua Khoo, Katherine Jackson, Chansavath Phetsouphanh, et al.
Immunity|November 17, 2021
Immunizations with diverse sarbecovirus receptor-binding domains elicit SARS-CoV-2 neutralizing antibodies against a conserved site of vulnerabilityDeborah L Burnett, Katherine J L Jackson, David B Langley, et al.
Nature Microbiology|May 31, 2022
Platform for isolation and characterization of SARS-CoV-2 variants enables rapid characterization of Omicron in AustraliaAnupriya Aggarwal, Alberto Ospina Stella, Gregory Walker, et al.
Nature Immunology|September 20, 2019
Denisovan, modern human and mouse TNFAIP3 alleles tune A20 phosphorylation and immunityNathan W Zammit, Owen M Siggs, Paul E Gray, et al.
Science Advances|March 12, 2025
Targeting the NPY/NPY1R signaling axis in mutant p53-dependent pancreatic cancer impairs metastasisCecilia R Chambers, Supitchaya Watakul, Peter Schofield, et al.
Pageof 10

Showing results (91-100 of 100) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 100 results.
Cell Reports|January 29, 2022
Maintenance of broad neutralizing antibodies and memory B cells 1 year post-infection is predicted by SARS-CoV-2-specific CD4+ T cell responsesHarikrishnan Balachandran, Chansavath Phetsouphanh, David Agapiou, et al.
Plos Medicine|July 6, 2021
SARS-CoV-2 neutralizing antibodies: Longevity, breadth, and evasion by emerging viral variantsFiona Tea, Alberto Ospina Stella, Anupriya Aggarwal, et al.
Journal of Clinical Immunology|April 30, 2021
Genomic Spectrum and Phenotypic Heterogeneity of Human IL-21 Receptor DeficiencyDeniz Cagdas, Daniel Mayr, Safa Baris, et al.
Nature Communications|August 14, 2019
CAF hierarchy driven by pancreatic cancer cell p53-status creates a pro-metastatic and chemoresistant environment via perlecanClaire Vennin, Pauline Mélénec, Romain Rouet, et al.
Cell|February 16, 2020
Lymphoma Driver Mutations in the Pathogenic Evolution of an Iconic Human AutoantibodyMandeep Singh, Katherine J L Jackson, Jing J Wang, et al.
Clinical Immunology (Orlando, Fla.)|December 20, 2022
Tracking the clonal dynamics of SARS-CoV-2-specific T cells in children and adults with mild/asymptomatic COVID-19Weng Hua Khoo, Katherine Jackson, Chansavath Phetsouphanh, et al.
Immunity|November 17, 2021
Immunizations with diverse sarbecovirus receptor-binding domains elicit SARS-CoV-2 neutralizing antibodies against a conserved site of vulnerabilityDeborah L Burnett, Katherine J L Jackson, David B Langley, et al.
Nature Microbiology|May 31, 2022
Platform for isolation and characterization of SARS-CoV-2 variants enables rapid characterization of Omicron in AustraliaAnupriya Aggarwal, Alberto Ospina Stella, Gregory Walker, et al.
Nature Immunology|September 20, 2019
Denisovan, modern human and mouse TNFAIP3 alleles tune A20 phosphorylation and immunityNathan W Zammit, Owen M Siggs, Paul E Gray, et al.
Science Advances|March 12, 2025
Targeting the NPY/NPY1R signaling axis in mutant p53-dependent pancreatic cancer impairs metastasisCecilia R Chambers, Supitchaya Watakul, Peter Schofield, et al.
Pageof 10